Protagonist Therapeutics Inc
- Stock Issuer and Owners
Protagonist Therapeutics Inc |
Ticker | PTGX |
CIK # | 0001377121 |
CUSIP | 74366E102 |
Sector | Life Sciences - Pharmaceutical Preparations |
Address | 521 Cottonwood Drive, Suite 100, Malpitas, CA 95035-7404 |
Source |
[EDGAR]
|
Form 13F Holdings |
Firm |
Period |
DFND |
Voting |
Shares |
RTW Investments LP |
[2023-03-31]
|
SOLE |
4,600,799.0 |
4,600,799.0 |
BlackRock Inc. |
[2023-03-31]
|
SOLE |
4,313,492.0 |
4,402,217.0 |
BVF Inc/IL |
[2023-03-31]
|
DFND |
0.0 |
3,775,900.0 |
Vanguard Group Inc |
[2023-03-31]
|
SOLE |
0.0 |
3,169,677.0 |
Farallon Capital Management LLC |
[2023-03-31]
|
OTR |
2,615,014.0 |
2,615,014.0 |
Adage Capital Partners GP LLC |
[2023-03-31]
|
SOLE |
2,558,000.0 |
2,558,000.0 |
Johnson & Johnson |
[2023-03-31]
|
DFND |
0.0 |
2,449,183.0 |
State Street Corp |
[2023-03-31]
|
DFND |
2,324,456.0 |
2,413,701.0 |
Cormorant Asset Management LP |
[2023-03-31]
|
DFND |
1,700,000.0 |
1,700,000.0 |
Citadel Advisors LLC |
[2023-03-31]
|
DFND |
1,646,480.0 |
1,646,480.0 |
Morgan Stanley |
[2023-03-31]
|
DFND |
1,559,750.0 |
1,570,510.0 |
Kynam Capital Management LP |
[2023-03-31]
|
SOLE |
1,375,000.0 |
1,375,000.0 |
Marshall Wace LLP |
[2023-03-31]
|
OTR |
0.0 |
1,366,080.0 |
Dimensional Fund Advisors LP |
[2023-03-31]
|
SOLE |
1,128,158.0 |
1,194,578.0 |
Millennium Management LLC |
[2023-03-31]
|
SOLE |
1,122,342.0 |
1,122,342.0 |
Perceptive Advisors LLC |
[2023-03-31]
|
SOLE |
965,152.0 |
965,152.0 |
Deutsche Bank AG |
[2023-03-31]
|
DFND |
52,130.0 |
958,891.0 |
Geode Capital Management LLC |
[2023-03-31]
|
DFND |
925,993.0 |
925,993.0 |
683 Capital Management LLC |
[2023-03-31]
|
DFND |
873,000.0 |
873,000.0 |
Susquehanna International Group LLP |
[2023-03-31]
|
DFND |
124,084.0 |
868,784.0 |
Nuveen Asset Management LLC |
[2023-03-31]
|
DFND |
828,471.0 |
828,471.0 |
Bank of America Corp /DE/ |
[2023-03-31]
|
DFND |
14,902.0 |
766,990.0 |
Renaissance Technologies LLC |
[2023-03-31]
|
SOLE |
690,867.0 |
690,867.0 |
Candriam SCA |
[2023-03-31]
|
SOLE |
625,000.0 |
625,000.0 |
Woodline Partners LP |
[2023-03-31]
|
SOLE |
618,615.0 |
618,615.0 |
Barclays PLC |
[2023-03-31]
|
SOLE |
583,737.0 |
583,737.0 |
Voloridge Investment Management LLC |
[2023-03-31]
|
SOLE |
465,323.0 |
465,323.0 |
Goldman Sachs Group Inc |
[2023-03-31]
|
DFND |
459,420.0 |
459,450.0 |
Two Sigma Advisers LP |
[2023-03-31]
|
SOLE |
377,600.0 |
449,800.0 |
Jennison Associates LLC |
[2023-03-31]
|
DFND |
428,938.0 |
428,938.0 |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 120731936, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
163924925